Published in JAMA Oncol on June 01, 2015
Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots. JAMA Oncol (2015) 2.62
Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women. J Natl Cancer Inst (2015) 1.44
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst (2016) 0.94
RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1. Stem Cell Reports (2015) 0.88
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy. Mol Cell Endocrinol (2015) 0.80
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Oncotarget (2016) 0.76
The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan. Int J Environ Res Public Health (2016) 0.75
Hormone Replacement Therapy, Likely Neither Angel Nor Demon. PLoS One (2015) 0.75
Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial. Menopause (2016) 0.75
Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. BMC Womens Health (2017) 0.75
Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study. J Am Coll Cardiol (2014) 1.56
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. JAMA (2017) 1.40
Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. J Gerontol A Biol Sci Med Sci (2014) 0.84
Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Neighborhood Walkability and Adiposity in the Women's Health Initiative Cohort. Am J Prev Med (2016) 0.79
Association Between Anthropometric Measures and Long-Term Survival in Frail Older Women: Observations from the Women's Health Initiative Study. J Am Geriatr Soc (2016) 0.79
Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2016) 0.78
Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults. J Am Geriatr Soc (2015) 0.77
Hormone therapy use and outcomes in the Women's Health Initiative trials--reply. JAMA (2014) 0.77
The Relationship of Cardiovascular Disease to Physical Functioning in Women Surviving to Age 80 and Above in the Women's Health Initiative. J Gerontol A Biol Sci Med Sci (2016) 0.76
Vitamin D insufficiency and abnormal hemoglobin a1c in black and white older persons. J Gerontol A Biol Sci Med Sci (2014) 0.76
Pet Ownership and Cancer Risk in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev (2016) 0.76
Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Aging Well: Observations From the Women's Health Initiative Study. J Gerontol A Biol Sci Med Sci (2016) 0.75
Adjuvant aromatase inhibitor options in overweight and obese postmenopausal women with breast cancer. Breast J (2013) 0.75
Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial. JAMA Intern Med (2017) 0.75
Smoking Habits and Body Weight Over the Adult Lifespan in Postmenopausal Women. Am J Prev Med (2016) 0.75